Literature DB >> 19066578

Generating iPS cells from MEFS through forced expression of Sox-2, Oct-4, c-Myc, and Klf4.

G Grant Welstead1, Tobias Brambrink, Rudolf Jaenisch.   

Abstract

Pluripotency can be induced in differentiated murine by viral transduction of Oct4, Sox2, Klf4, and c-Myc (Takahashi and Yamanaka, 2006; Wernig, et al., 2007; Okita, et al., 2007; Maherali, et al., 2007). We have devised a reprogramming strategy in which these four transcription factors are expressed from doxycycline (dox)-inducible lentiviral vectors (Brambrink et al., 2008). Using these inducible constructs, we can derive induced pluripotent stem (iPS) cells from mouse embryonic fibroblasts (MEFs). In this video, we demonstrate the procedure for the generation of inducible lentiviruses that express the four transcription factors and show how to infect MEFs with these viruses in order to produce iPS cells. By using inducible lentiviruses, the expression of the four factors in controlled by the addition of doxycyline to the culture medium. The advantage of this system over the traditional retroviral infection is the ability to turn the genes on and off so that the kinetics of reprogramming and gene expression requirements can be analyzed in detail.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066578      PMCID: PMC2582849          DOI: 10.3791/734

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  5 in total

1.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

2.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

3.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

4.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

5.  Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.

Authors:  Tobias Brambrink; Ruth Foreman; G Grant Welstead; Christopher J Lengner; Marius Wernig; Heikyung Suh; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2008-02-07       Impact factor: 24.633

  5 in total
  22 in total

1.  [Mesenchymal stem cells for bone tissue engineering].

Authors:  R K Schneider; S Neuss; R Knüchel; A Perez-Bouza
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

2.  High-efficiency transduction of fibroblasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapy.

Authors:  Mengxin Li; Giridhara R Jayandharan; Baozheng Li; Chen Ling; Wenqin Ma; Arun Srivastava; Li Zhong
Journal:  Hum Gene Ther       Date:  2010-10-06       Impact factor: 5.695

3.  Differentiation of human adipose-derived stem cells into neuron-like cells which are compatible with photocurable three-dimensional scaffolds.

Authors:  Shane Gao; Peng Zhao; Chao Lin; Yuxi Sun; Yilei Wang; Zhichong Zhou; Danjing Yang; Xianli Wang; Hongzhen Xu; Fei Zhou; Limei Cao; Wei Zhou; Ke Ning; Xu Chen; Jun Xu
Journal:  Tissue Eng Part A       Date:  2014-04       Impact factor: 3.845

4.  Human iPSC Glial Mouse Chimeras Reveal Glial Contributions to Schizophrenia.

Authors:  Martha S Windrem; Mikhail Osipovitch; Zhengshan Liu; Janna Bates; Devin Chandler-Militello; Lisa Zou; Jared Munir; Steven Schanz; Katherine McCoy; Robert H Miller; Su Wang; Maiken Nedergaard; Robert L Findling; Paul J Tesar; Steven A Goldman
Journal:  Cell Stem Cell       Date:  2017-07-20       Impact factor: 24.633

5.  MIR144 and MIR451 regulate human erythropoiesis via RAB14.

Authors:  MinJung Kim; Yee Sun Tan; Wen-Chih Cheng; Tami J Kingsbury; Shelly Heimfeld; Curt I Civin
Journal:  Br J Haematol       Date:  2014-10-14       Impact factor: 6.998

6.  Dysregulated Glial Differentiation in Schizophrenia May Be Relieved by Suppression of SMAD4- and REST-Dependent Signaling.

Authors:  Zhengshan Liu; Mikhail Osipovitch; Abdellatif Benraiss; Nguyen P T Huynh; Rossana Foti; Janna Bates; Devin Chandler-Militello; Robert L Findling; Paul J Tesar; Maiken Nedergaard; Martha S Windrem; Steven A Goldman
Journal:  Cell Rep       Date:  2019-06-25       Impact factor: 9.423

Review 7.  Translating induced pluripotent stem cells from bench to bedside: application to retinal diseases.

Authors:  Alona O Cramer; Robert E MacLaren
Journal:  Curr Gene Ther       Date:  2013-04       Impact factor: 4.391

8.  Octamer-binding factor 6 (Oct-6/Pou3f1) is induced by interferon and contributes to dsRNA-mediated transcriptional responses.

Authors:  Elisabeth Hofmann; Ursula Reichart; Christian Gausterer; Christian Guelly; Dies Meijer; Mathias Müller; Birgit Strobl
Journal:  BMC Cell Biol       Date:  2010-08-05       Impact factor: 4.241

Review 9.  Cellular and molecular chaperone fusion vaccines: targeting resistant cancer cell populations.

Authors:  Stuart K Calderwood; Jianlin Gong; Mary Ann Stevenson; Ayesha Murshid
Journal:  Int J Hyperthermia       Date:  2013-05-17       Impact factor: 3.914

10.  Genetic background affects induced pluripotent stem cell generation.

Authors:  Lauren V Schnabel; Christian M Abratte; John C Schimenti; Teresa L Southard; Lisa A Fortier
Journal:  Stem Cell Res Ther       Date:  2012-08-03       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.